The HPV Testing and Pap Test Market size in the Asia Pacific was around USD 0.59 million in 2020. It is expected to grow at a CAGR of 6.7% to reach USD 0.82 million by 2025. It captures 15% of the global market.
The increasing incidence of infectious diseases in developing nations of Asia Pacific countries and growing awareness in people through the governments' various campaigns regarding the early cancer examination is majorly supporting the market's growth in this region. Rapid developments in the healthcare industry and the growing number of cancer cases in this region are further significant to the Asia-Pacific HPV Testing and Pap Test Market.
The escalating number of cervical cases is a positive sign of the growth rate of the market. For instance, in February 2014, Qiagen introduced the careHPV test in India, and the invention of this novel diagnostic examination is projected to enlarge the protective screening measures opposing cervical cancer. Furthermore, growth in the number of hospital construction, increasing developments in the early diagnosis of the diseases are also contributing to the growth of the market.
Unfavorable reimbursement policies are expected to hinder the growth of the HPV testing and PAP test market in the Asia-Pacific to a small extent.
This research report on the Asia Pacific HPV Testing and Pap Test Market has been segmented and sub-segmented into the following categories:
By Test Type:
By Application:
By End-users:
By Country:
Regionally, it is the third-largest market in terms of market share and second largest in terms of CAGR. China is the leading market in this region due to the rising old age people population; a rise in the healthcare sector and increasing applications from existing nations will further accelerate the opportunities leading to the growth of the HPV and PAP test market in the region.
Indian HPV testing and PAP test market is expected to be more lucrative during the forecast period. The Indian government has taken a few measures generalizing examination programs, which is estimated to flourish the market growth in the region throughout the assessment period. Increase in R & D investments for inventing products and technologies augmenting the market growth in the area.
Notable companies dominating the Asia Pacific HPV Testing and PAP Test Market profiled in this report are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., and Arbor Vita Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 HPV Testing
5.1.3 Follow-Up HPV Testing
5.1.4 Co-Testing
5.1.5 Primary HPV Testing
5.1.6 PAP Test
5.1.7 Y-o-Y Growth Analysis, By Type
5.1.8 Market Attractiveness Analysis, By Type
5.1.9 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Cervical Cancer Screening
5.2.3 Vaginal Cancer Screening
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Laboratories
5.3.3 Hospitals
5.3.4 Physicians’ Offices and Clinics
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Qiagen N.V.
8.3 Roche Diagnostics
8.4 Hologic, Inc.
8.5 Becton, Dickinson and Company
8.6 Quest Diagnostics
8.7 Onco Health Corporation
8.8 Seegene, Inc.
8.9 Femasys Inc.
8.10 Arbor Vita Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
